J Clin Pharm Ther (2017) 42(4):394403.10.1111/jcpt.12548 Summary Keywords riboflavin, Parkinsons disease, migraine, oxidative stress, glutamate excitotoxicity, pyridoxal phosphate, homocysteine, kynurenine Citation Marashly ET and Bohlega SA (2017) Riboflavin Has Neuroprotective Potential: Focus on Parkinsons Disease and Migraine
Smaller Novartis Post-Sandoz Grows Core Business Novartiss slippage on the league table in 2024 reflects the spin-out of its Sandoz generics and biosimilars business in October 2023
Kapeta, S., N
Court-mandated diagnostic standards, two parallel MDLs with distinct injury profiles, and compressed timelines before bellwether trials all point to the same conclusion: complete medical record retrievalacross multiple provider typesis no longer optional
"We have spent years building the infrastructure required to put the power of choice back into the hands of the individual, and we are committed to ensuring providers can always make the best clinical decision for their patients with an array of safe options to help find care that fits their lifestyle, Hims & Hers CEO Andrew Dudum said in a statement
